Michaela Moserová

701 total citations
33 papers, 642 citations indexed

About

Michaela Moserová is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Michaela Moserová has authored 33 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 20 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Michaela Moserová's work include Pharmacogenetics and Drug Metabolism (18 papers), Cancer therapeutics and mechanisms (12 papers) and Carcinogens and Genotoxicity Assessment (9 papers). Michaela Moserová is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Cancer therapeutics and mechanisms (12 papers) and Carcinogens and Genotoxicity Assessment (9 papers). Michaela Moserová collaborates with scholars based in Czechia, Germany and United Kingdom. Michaela Moserová's co-authors include Marie Stiborová, Eva Frei, Volker M. Arlt, Heinz H. Schmeiser, Radek Indra, Miroslav Šulc, David H. Phillips, C. Roland Wolf, Colin J. Henderson and Petr Hodek and has published in prestigious journals such as International Journal of Molecular Sciences, Biochemical Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Michaela Moserová

33 papers receiving 630 citations

Peers

Countries citing papers authored by Michaela Moserová

Since Specialization

Citations

This map shows the geographic impact of Michaela Moserová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Moserová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Moserová more than expected).

Fields of papers citing papers by Michaela Moserová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Moserová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Moserová. The network helps show where Michaela Moserová may publish in the future.

Co-authorship network of co-authors of Michaela Moserová

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Moserová. A scholar is included among the top collaborators of Michaela Moserová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Moserová. Michaela Moserová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of hepatic cytochrome b/P450 reductase null (HBRN) mice to study the role of cytochrome b in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine 2019 ·Toxicology and Applied Pharmacology ·(unknown), Radek Indra, (unknown), Michaela Moserová, Heinz H. Schmeiser, C. Roland Wolf, Colin J. Henderson, Marie Stiborová, David H. Phillips, Volker M. Arlt	2
2	Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice 2018 ·Archives of Toxicology ·(unknown), (unknown), (unknown), Radek Indra, Michaela Moserová, Klaus Kopka, Heinz H. Schmeiser, C. Roland Wolf, Colin J. Henderson, Marie Stiborová, David H. Phillips, Volker M. Arlt	25
3	Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems 2017 ·Monatshefte für Chemie - Chemical Monthly ·Marie Stiborová, Radek Indra, Michaela Moserová, Lucie Bořek-Dohalská, Petr Hodek, Eva Frei, Klaus Kopka, Heinz H. Schmeiser, Volker M. Arlt	10
4	Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine 2016 ·Monatshefte für Chemie - Chemical Monthly ·(unknown), Michaela Moserová, (unknown), Miroslav Šulc, René Kizek, Kateřina Kubáčková, Volker M. Arlt, Marie Stiborová	5
5	NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[a]pyrene catalyzed with rat hepatic microsomes and cytochrome P450 1A1 2016 ·Monatshefte für Chemie - Chemical Monthly ·Marie Stiborová, Radek Indra, Michaela Moserová, Miroslav Šulc, Petr Hodek, Eva Frei, Heinz H. Schmeiser, Volker M. Arlt	12
6	Induced expression of microsomal cytochrome b 5 determined at mRNA and protein levels in rats exposed to ellipticine, benzo[a]pyrene, and 1-phenylazo-2-naphthol (Sudan I) 2016 ·Monatshefte für Chemie - Chemical Monthly ·Marie Stiborová, Michaela Moserová, (unknown), (unknown), Václav Martínek, Radek Indra, Eva Frei, Vojtěch Adam, René Kizek, Heinz H. Schmeiser, Kateřina Kubáčková, Volker M. Arlt	3
7	Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo 2016 ·Toxicology ·(unknown), (unknown), Kateřina Levová, (unknown), Michaela Moserová, Heinz H. Schmeiser, Klaus Kopka, Eva Frei, Volker M. Arlt, Marie Stiborová	24
8	The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice 2015 ·Archives of Toxicology ·(unknown), Ewoud N. Speksnijder, Joost P.M. Melis, Radek Indra, Michaela Moserová, Roger Godschalk, (unknown), Albrecht Seidel, Klaus Kopka, Heinz H. Schmeiser, Marie Stiborová, David H. Phillips, Mirjam Luijten, Volker M. Arlt	38
9	Chicken immunoglobulins for prophylaxis: Effect of inhaled antibodies on inflammatory parameters in rat airways 2014 ·Journal of Applied Biomedicine ·(unknown), (unknown), (unknown), Michaela Moserová, (unknown), Václav Mandys, Marie Stiborová, Ilja Střı́ž, Petr Hodek	5
10	Cytochrome b and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions 2014 ·Toxicology ·Marie Stiborová, Michaela Moserová, (unknown), Radek Indra, Martin Dračínský, Miroslav Šulc, Colin J. Henderson, C. Roland Wolf, Heinz H. Schmeiser, David H. Phillips, Eva Frei, Volker M. Arlt	44
11	Effect of dihydromyricetin on benzo[a]pyrene activation in rats. 2014 ·PubMed ·Petr Hodek, (unknown), (unknown), Michaela Moserová, Petr Pávek, Eva Anzenbacherová, (unknown), Jiřı́ Hudeček, Eva Frei, Marie Stiborová	4
12	Oxidation of carcinogenic benzo[a]pyrene by human and rat CYP1A1 and its influencing by cytochrome b5—A comparative study 2013 ·Toxicology Letters ·Radek Indra, Michaela Moserová, Miroslav Šulc, Marie Stiborová	1
13	NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I 2012 ·Toxicology and Applied Pharmacology ·Kateřina Levová, Michaela Moserová, Daniel W. Nebert, David H. Phillips, Eva Frei, Heinz H. Schmeiser, Volker M. Arlt, Marie Stiborová	25
14	Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling 2012 ·Toxicology Letters ·Volker M. Arlt, Miriam C. Poirier, (unknown), Kaarthik John, Michaela Moserová, Marie Stiborová, C. Roland Wolf, Colin J. Henderson, David H. Phillips	32
15	Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy 2011 ·Biochemical Pharmacology ·(unknown), (unknown), Michaela Moserová, Václav Martínek, Petr Hodek, Jiřı́ Hudeček, Eva Frei, Marie Stiborová	46
16	Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model 2011 ·Toxicological Sciences ·Kateřina Levová, Michaela Moserová, (unknown), Miroslav Šulc, Colin J. Henderson, C. Roland Wolf, David H. Phillips, Eva Frei, Heinz H. Schmeiser, Jaroslav Mareš, Volker M. Arlt, Marie Stiborová	51
17	Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method 2009 ·Interdisciplinary Toxicology ·Michaela Moserová, (unknown), Dagmar Aimová, Miroslav Šulc, Eva Frei, Marie Stiborová	25
18	Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2 2008 ·Interdisciplinary Toxicology ·Dagmar Aimová, Jitka Poljaková, (unknown), Michaela Moserová, Eva Frei, Volker M. Arlt, Marie Stiborová	9
19	Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA. 2008 ·PubMed ·Michaela Moserová, (unknown), (unknown), (unknown), Jiřı́ Hudeček, Petr Hodek, Eva Frei, Marie Stiborová	8
20	Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse 2007 ·Toxicology and Applied Pharmacology ·Marie Stiborová, Volker M. Arlt, Colin J. Henderson, C. Roland Wolf, (unknown), Michaela Moserová, Jiřı́ Hudeček, David H. Phillips, Eva Frei	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact